Professor Serves as Lead Advocate for Cyberbullying Legislation
New York Governor Kathy Hochul signed legislation designed to eradicate cyberbullying thanks to lead advocacy from Lisa-Michelle Kucharz, professor of communications. Kucharz’s efforts inspired...
News Station Highlights Campus Nutritionists
News 12 featured the work of student nutritionists on the Post campus during National Nutrition Month in March. Using a variety of creative demonstrations...
Holm Named National Semi-Finalist for Goalie of the Year
Tindra Holm, a junior from Skellefteå, Sweden, was named by the Women's Hockey Commissioners Association as a semifinalist for the 2024 Women's Hockey Goalie...
LIU Professor Speaks at Yale
Dr. Yafeng Xia, Professor of History, delivered a guest lecture at Yale University’s international conference “The End of the Cold War: Continuity and Change...
Alumnus Selected to Lead Global Organization
Jeffrey Melnick ’92 was named chief financial officer of ETS, a global educational assessment and data organization. Melnick previously held leadership roles with EisnerAmper, one of the...
Pharmaceutical Specialist Joins International Drug Developer
Ami Patel ’05, ’16 was selected as the senior director of product development for Boyds, a global pharmaceutical consultancy service supporting the development of...
Alumnus Leads Pharmaceutical Company Board of Directors
Dieter Weinand ’87 was appointed as the Chair of the Board of Directors at Umoja Biopharma, Inc., an immuno-oncology company that develops therapeutics to reprogram immune cells to treat cancer patients. Weinand...
Prestigious Alumnus Joins Forbes Top 30 Wealthiest Americans
Ray Dalio, founder and co-chief investment officer of the world’s largest hedge fund, Bridgewater Associates, moved into the top 30 wealthiest people in America...
Vet Students Earn Scholarships
Seniors Alyssa Buback and Charlotte Kozlowski and graduate students Cayla Fisher, Erinn Hewett and Cayden Smith were among 20 students across the country to...
Weinand Named Chairman at Replimune Group
Dieter Weinand (MS ’87) was appointed Chairman of the Board of Directors at Replimune Group Inc. (REPL), a biotechnology company developing oncolytic immuno-gene therapies....